The civic record
Read. Follow. Verify.Rhode Island Bill Caps Prescription Inhaler and Device Costs at $25 Per Month
Last action · April 29, 2026: Referred to House Health & Human ServicesSponsors: Melissa Murray and 6 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Rhode Island lawmakers are advancing a measure that limits out-of-pocket costs for covered prescription inhalers, devices, and equipment to $25 per 30-day supply. The bill passed the Senate and is currently awaiting action in a House committee.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
covered persons
health insurance providers
Insurers must adjust their prescription drug benefit structures to comply with the maximum cost limit for covered respiratory devices and inhalers.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is the maximum amount I can be charged for an inhaler under this bill?
What types of products are covered by this price cap?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · passed the Senate · in House committee.
Procedural history
6 actions- Apr 29, 2026CommitteeReferred to House Health & Human Services
- Apr 28, 2026FloorSenate read and passed
- Apr 15, 2026Placed on Senate Calendar (04/28/2026)
- Apr 14, 2026FloorCommittee recommends passage
- Apr 10, 2026Scheduled for hearing and/or consideration (04/14/2026)
- Mar 4, 2026IntroducedIntroduced, referred to Senate Health and Human Services
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
status.rilegislature.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools